Gene · 2642
Papers2,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide. | Org Lett | 2026 | 42224238 | PubTator, text mining | PubMed |
Do Glucagon-Like Peptide-1 Receptor Agonists Sabotage Fat Grafts?: A Scoping Review of Glucagon-Like Peptide-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer. | Aesthet Surg J | 2026 | 42219269 | PubTator, text mining | PubMed |
| Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial. | Diabetes Obes Metab | 2026 | 42219222 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression. | Medicina (Kaunas) | 2026 | 42195239 | PubTator, text mining | PubMed |
| Kynurenic acid mediates epicardial fat-induced lymphatic metabolic dysfunction in atrial fibrillation. | Nat Commun | 2026 | 42156758 | PubTator, text mining | PubMed |
| Amping Up Receptor Balance and Bias: Fine Tuning of Unimolecular Multiagonists. | J Med Chem | 2026 | 42152230 | PubTator, text mining | PubMed |
| [Current and future medical treatments for metabolic dysfunction-associated steatohepatitis]. | Rev Prat | 2026 | 42083849 | PubTator, text mining | PubMed |
| Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart. | Pharmaceutics | 2026 | 42076099 | PubTator, text mining | PubMed |
| Postprandial Glucagon Action in the Human Brain. | Diabetes Obes Metab | 2026 | 42017287 | PubTator, text mining | PubMed |
| Novel Small Molecule GLP-1R Agonists Based on 1H-Benzo[d]imidazole-5-Carboxylic Acid Scaffold. | Molecules | 2026 | 41976172 | PubTator, text mining | PubMed |
| The Glucagonocentric Basis of Diabetic Cardiomyopathy: Pancreas-Heart Crosstalk Linking α-Cell Dysregulation to Cardiac Metabolic Stress and Fibrosis. | Compr Physiol | 2026 | 41947455 | PubTator, text mining | PubMed |
| Recent advances in incretin biology and therapeutics: From glucose-dependent insulinotropic polypeptide reappraisal to next-generation agonists. | J Diabetes Investig | 2026 | 41928613 | PubTator, text mining | PubMed |
| Improving incretin-mediated body weight loss via energy expenditure. | Trends Endocrinol Metab | 2026 | 41904104 | PubTator, text mining | PubMed |
| Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox. | Metabolites | 2026 | 41893325 | PubTator, text mining | PubMed |
| Origins of Avian Hyperactive Mitochondria, Genome Compaction, and Air-Sac Physiology in Early Theropods During the Carnian Pluvial Episode. | J Dev Biol | 2026 | 41892809 | PubTator, text mining | PubMed |
| Efficacy and safety of pemvidutide in metabolic dysfunction-associated steatohepatitis: a GRADE-assessed meta-analysis of randomized controlled trials. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41879841 | PubTator, text mining | PubMed |
| Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG1 antibodies. | Proc Natl Acad Sci U S A | 2026 | 41875154 | PubTator, text mining | PubMed |
| Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity. | RSC Med Chem | 2026 | 41869515 | PubTator, text mining | PubMed |
| Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans. | Cell Rep Med | 2026 | 41850248 | PubTator, text mining | PubMed |
| Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes. | Expert Opin Ther Pat | 2026 | 41820018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2642/papers?page=3